Neurokinin3 receptor antagonism attenuates cocaine's behavioural activating effects yet potentiates its dopamine-enhancing action in the nucleus accumbens core

European Journal of Neuroscience

Volumn 24, Issue 6, 2006, Pages 1721-1732

  Jocham, Gerhard ^a   Lezoch, Katharina ^a   Müller, Christian P ^a   Kart Teke, Emriye ^a   Huston, Joseph P ^a   De Souza Silva, M Angélica ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Cocaine; NK3 receptors; Rats; Reinforcement; SR142801

Indexed keywords

COCAINE; DOPAMINE; NEUROKININ 3 RECEPTOR; NEUROKININ 3 RECEPTOR ANTAGONIST; OSANETANT; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE UPTAKE INHIBITOR; HOMOVANILLIC ACID; NEUROLEPTIC AGENT; PIPERIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; HYPERACTIVITY; IN VIVO STUDY; LOCOMOTION; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INTERACTION; EXTRACELLULAR FLUID; INSTRUMENTAL CONDITIONING; METABOLISM; METHODOLOGY; PHYSIOLOGY; WISTAR RAT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING, OPERANT; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXTRACELLULAR FLUID; HOMOVANILLIC ACID; LOCOMOTION; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, NEUROKININ-3;

EID: 33748899823     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05041.x     Document Type: Article

References (47)

1. Barnes, J.M., Barnes, N.M., Costall, B., Cox, A.J., Domeney, A.M., Kelly, M.E. & Naylor, R.J. (1990) Neurochemical consequences following injection of the substance P analogue, DiMe-C7, into the rat ventral tegmental area. Pharmacol. Biochem. Behav., 37, 839-841.
2. Boix, F., Huston, J.P. & Schwarting, R.K. (1992a) The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats. Brain Res., 592, 181-186.
3. Boix, F., Mattioli, R., Adams, F., Huston, J.P. & Schwarting, R.K. (1992b) Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbens. Eur. J. Pharmacol., 216, 103-107.
4. Boix, F., Sandor, P., Nogueira, P.J., Huston, J.P. & Schwarting, R.K. (1995) Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience, 64, 1045-1055.
5. Chen, L.W., Guan, Z.L. & Ding, Y.Q. (1998) Mesencephalic dopaminergic neurons expressing neuromedin K receptor (NK3): a double immunocytochemical study in the rat. Brain Res., 780, 150-154.
6. Ciccocioppo, R., Panocka, I., Polidori, C., Froldi, R., Angeletti, S. & Massi, M. (1998) Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide. Pharmacol. Biochem. Behav., 61, 459-464.
7. Ciccocioppo, R., Panocka, I., Pompei, P., Polidori, C., De Caro, G. & Massi, M. (1995) Subcutaneous injections of the tachykinin senktide reduce alcohol intake in alcohol-preferring rats. Peptides, 16, 533-537.
8. Deutch, A.Y. & Cameron, D.S. (1992) Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience, 46, 49-56.
9. Di Chiara, G. (2002) Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav. Brain Res., 137, 75-114.
10. Di Chiara, G., Bassareo, V., Fenu, S., De Luca, M.A., Spina, L., Cadoni, C., Acquas, E., Carboni, E., Valentini, V. & Lecca, D. (2004) Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology, 47, 227-241.
11. Ding, Y.Q., Shigemoto, R., Takada, M., Ohishi, H., Nakanishi, S. & Mizuno, N. (1996) Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat. J. Comp. Neurol., 364, 290-310.
12. Eison, A.S., Eison, M.S. & Iversen, S.D. (1982) The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area or substantia nigra of rat brain. Brain Res., 238, 137-152.
13. Elliott, P.J., Mason, G.S., Stephens-Smith, M. & Hagan, R.M. (1991) Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists. Neuropeptides, 19, 119-126.
14. Emonds-Alt, X., Bichon, D., Ducoux, J.P., Heaulme, M., Miloux, B., Poncelet, M., Proietto, V., Van Broeck, D., Vilain, P. & Neliat, G. (1995) SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sci., 56, L27-L32.
15. Goeders, N.E. & Smith, J.E. (1993) Intracranial cocaine self-administration into the medial prefrontal cortex increases dopamine turnover in the nucleus accumbens. J. Pharmacol. Exp. Ther., 265, 592-600.
16. Groenewegen, H.J., Wright, C.I. & Beijer, A.V. (1996) The nucleus accumbens: gateway for limbic structures to reach the motor system? Prog. Brain Res., 107, 485-511.
17. Hasenöhrl, R.U., de Souza-Silva, M.A., Nikolaus, S., Tomaz, C., Brandao, M.L., Schwarting, R.K. & Huston, J.P. (2000) Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides, 34, 274-280.
18. Hasenöhrl, R.U., Gerhardt, P. & Huston, J.P. (1990) Evidence for dose-dependent positively and negatively reinforcing effects of the substance P C-terminal analog DIME-C7. Neuropeptides, 17, 205-211.
19. Hasenöhrl, R.U., Gerhardt, P. & Huston, J.P. (1992) Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence. Exp. Neurol., 115, 282-291.
20. Hasenöhrl, R.U., Oitzl, M.S. & Huston, J.P. (1989) Conditioned place preference in the corral: a procedure for measuring reinforcing properties of drugs. J. Neurosci. Meth., 30, 141-146.
21. Jung, M., Michaud, J.C., Steinberg, R., Barnouin, M.C., Hayar, A., Mons, G., Souilhac, J., Emonds-Alt, X., Soubrie, P. & Le Fur, G. (1996) Electrophysiological, behavioural and biochemical evidence for activation of brain noradrenergic systems following neurokinin NK3 receptor stimulation. Neuroscience, 74, 403-414.
22. Kelley, A.E., Stinus, L. & Iversen, S.D. (1979) Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones. Neurosci. Lett., 11, 335-339.
23. Krappmann, P., Hasenöhrl, R.U., Frisch, C. & Huston, J.P. (1994) Self-administration of neurokinin substance P into the ventromedial caudate-putamen in rats. Neuroscience, 62, 1093-1101.
24. Langlois, X., te Riele, P., Wintmolders, C., Leysen, J.E. & Jurzak, M. (2001a) Use of the beta-imager for rapid ex vivo autoradiography exemplified with central nervous system penetrating neurokinin 3 antagonists. J. Pharmacol. Exp. Ther., 299, 712-717.
25. Langlois, X., Wintmolders, C., te Riele, P., Leysen, J.E. & Jurzak, M. (2001b) Detailed distribution of neurokinin 3 receptors in the rat, guinea pig and gerbil brain: a comparative autoradiographic study. Neuropharmacology, 40, 242-253.
26. Marco, N., Thirion, A., Mons, G., Bougault, I., Le Fur, G., Soubrie, P. & Steinberg, R. (1998) Activation of dopaminergic and cholinergic neurotransmission by tachykinin NK3 receptor stimulation: an in vivo microdialysis approach in guinea pig. Neuropeptides, 32, 481-488.
27. Massi, M., Panocka, I. & De Caro, G. (2000) The psychopharmacology of tachykinin NK-3 receptors in laboratory animals. Peptides, 21, 1597-1609.
28. Müller, C.P., de Souza Silva, M.A., DePalma, G., Tomaz, C., Carey, R.J. & Huston, J.P. (2002) The selective serotonin (1A) -receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase. Behav. Brain Res., 134, 337-346.
29. Müller, C.P. & Huston, J.P. (2006) Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine. Trends Pharmacol. Sci., 27, 105-112.
30. Nguyen, L., Nguyen, Q.T., Gobeil, F., Pheng, L.H., Emonds-Alt, X., Breliere, J.C. & Regoli, D. (1996) Pharmacological characterization of SR 142801: a new non-peptide antagonist of the neurokinin NK-3 receptor. Pharmacology, 52, 283-291.
31. Nikolaus, S., Huston, J.P. & Hasenöhrl, R.U. (1999) Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor. Eur. J. Pharmacol., 370, 93-99.
32. Paxinos, G. & Watson, C. (1986) The Rat Brain in Stereotactic Coordinates. Academic Press, New York.
33. Placenza, F.M., Fletcher, P.J., Rotzinger, S. & Vaccarino, F.J. (2004) Infusion of the substance P analogue, DiMe-C7, into the ventral tegmental area induces reinstatement of cocaine-seeking behaviour in rats. Psychopharmacology (Berl), 177, 111-120.
34. Pontieri, F.E., Tanda, G. & Di Chiara, G. (1995) Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the 'shell' as compared with the 'core' of the rat nucleus accumbens. Proc. Natl Acad. Sci. USA, 92, 12304-12308.
35. Regoli, D., Boudon, A. & Fauchere, J.L. (1994) Receptors and antagonists for substance P and related peptides. Pharmacol. Rev., 46, 551-599.
36. Rodd-Henricks, Z.A., McKinzie, D.L., Li, T.K., Murphy, J.M. & McBride, W.J. (2002) Cocaine is self-administered into the shell but not the core of the nucleus accumbens of Wistar rats. J. Pharmacol. Exp. Ther., 303, 1216-1226.
37. Sarau, H.M., Griswold, D.E., Bush, B., Potts, W., Sandhu, P., Lundberg, D., Foley, J.J., Schmidt, D.B., Webb, E.F., Martin, L.D., Legos, J.J., Whitmore, R.G., Barone, F.C., Medhurst, A.D., Luttmann, M.A., Giardina, G.A. & Hay, D.W. (2000) Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist. J. Pharmacol. Exp. Ther., 295, 373-381.
38. Seabrook, G.R., Bowery, B.J. & Hill, R.G. (1995) Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices. Eur. J. Pharmacol., 273, 113-119.
39. Shughrue, P.J., Lane, M.V. & Merchenthaler, I. (1996) In situ hybridization analysis of the distribution of neurokinin-3 mRNA in the rat central nervous system. J. Comp. Neurol., 372, 395-414.
40. Sora, I., Hall, F.S., Andrews, A.M., Itokawa, M., Li, X.F., Wei, H.B., Wichems, C., Lesch, K.P., Murphy, D.L. & Uhl, G.R. (2001) Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. Proc. Natl Acad. Sci. USA, 98, 5300-5305.
41. de Souza Silva, M.A., Mello, E.L., Müller, C.P., Jocham, G., Major, R.S., Huston, J.P., Tomaz, C. & Barros, M. (2006) The tachykinin NK-3 receptor antagonist SR142801 blocks the behavioural effects of cocaine in marmoset monkeys. Eur. J. Pharmacol., 536, 269-278.
42. Stoessl, A.J. (1994) Localization of striatal and nigral tachykinin receptors in the rat. Brain Res., 646, 13-18.
43. Stoessl, A.J., Brackstone, M., Rajakumar, N. & Gibson, C.J. (1995) Pharmacological characterization of grooming induced by a selective NK-1 tachykinin receptor agonist. Brain Res., 700, 115-120.
44. Stoessl, A.J., Dourish, C.T. & Iversen, S.D. (1990) Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT. Brain Res., 517, 111-116.
45. Stoessl, A.J., Szczutkowski, E., Glenn, B. & Watson, I. (1991) Behavioural effects of selective tachykinin agonists in midbrain dopamine regions. Brain Res., 565, 254-262.
46. Woolverton, W.L. & Johnson, K.M. (1992) Neurobiology of cocaine abuse. Trends Pharmacol. Sci., 13, 193-200.
47. Zahm, D.S. & Brog, J.S. (1992) On the significance of subterritories in the 'accumbens' part of the rat ventral striatum. Neuroscience, 50, 751-767.